Edesa Biotech EV/EBIT
Что обозначает EV/EBIT в Edesa Biotech?
EV/EBIT Edesa Biotech, Inc. является N/A
Какое определение для EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT компаний в Health Care сектор на NASDAQ по сравнению с Edesa Biotech
Что делает Edesa Biotech?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Компании с ev/ebit похож на Edesa Biotech
- Telesis Bio Inc имеет EV/EBIT из N/A
- Iterum Therapeutics Plc имеет EV/EBIT из N/A
- Nuformix Plc имеет EV/EBIT из N/A
- Alvo Minerals Ltd имеет EV/EBIT из N/A
- NCS Multistage Inc имеет EV/EBIT из N/A
- DarioHealth Corp имеет EV/EBIT из N/A
- Edesa Biotech имеет EV/EBIT из N/A
- Eupraxia Pharmaceuticals имеет EV/EBIT из N/A
- QDM International имеет EV/EBIT из N/A
- Orion Nutraceuticals Inc имеет EV/EBIT из N/A
- Hopefield Ventures Inc имеет EV/EBIT из N/A
- Delta Drone SA имеет EV/EBIT из N/A
- Sable Resources имеет EV/EBIT из N/A